Krishna Institute of Medical Sciences share price
NSE: KIMSBSE: 543308Healthcare ServicesSmall Cap
Krishna Institute of Medical Sciences Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 2021 · Issue price ₹825
Last close ₹697.65up ₹28.05 (4.19%)BSE ₹698.20
Share price at the NSE close on 27 Oct 2026. Previous close ₹669.60.
27 Oct: open ₹666.60, high ₹701.00, low ₹661.55
52-week range of traded prices to 27 Oct 2026
₹575.80Low, 27 Jan 2026₹858.00High, 6 Jul 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹29,302 Cr285th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 143.28
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 13.04
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 9.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.27
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,03,49243.0% delivered
About Krishna Institute of Medical Sciences
Krishna Institute of Medical Sciences Limited runs KIMS Hospitals, a hospital network across Telangana, Andhra Pradesh, Maharashtra, Karnataka and Kerala, based in Secunderabad, Telangana.123 Its hospitals offer tertiary and quaternary care (complex treatment that needs specialists and advanced equipment) in fields such as cardiac sciences, transplants, critical care, oncology and robotic surgery.45
It was incorporated in 1973.2 It grew from a single hospital in Nellore over about 25 years, and listed its shares on Indian stock exchanges in 2021.16 It acquired Sunshine Hospitals and opened its first hospitals outside the Telugu-speaking states (Telangana and Andhra Pradesh), in Nagpur and Nashik.7 Besides the hospitals it owns, it runs hospitals owned by others under operations and management (O&M) agreements, such as those at Guntur, Sangli and Kompally.89 Its doctor partnership hospitals, in which doctors hold equity, include KIMS Sunshine in Begumpet and Gachibowli, KIMS-Manavata in Nashik and KIMS Hospitals Bengaluru.1011
The company's founder, chairman and managing director is Bhaskara Rao Bollineni, a cardiothoracic surgeon; his son Abhinay Bollineni is executive director and chief executive.1213 Promoters held 32.5% of the shares at the end of Jun 2026, and the top institutional holders the company lists included the mutual funds of SBI, Axis and HDFC.14
Krishna Institute of Medical Sciences key points
Results
- In the year to Mar 2026, consolidated revenue rose 28.2% to ₹39,308 million from ₹30,670 million, and EBITDA (earnings before interest, tax, depreciation and amortisation) rose 1.6% to ₹8,282 million from ₹8,148 million.15
- Consolidated profit after tax fell 41.7% to ₹2,420 million in the year to Mar 2026 from ₹4,148 million; the company attributed this to the start-up costs of its expansion.16
- In the quarter to Jun 2026, consolidated revenue from operations rose 35.3% from a year earlier to ₹1,180 crore, and consolidated EBITDA before Ind AS (Indian accounting standards) adjustments, as the company presents it, rose 14.6% to ₹222 crore.17
- Profit after tax for the quarter to Jun 2026 was ₹37 crore, against ₹85 crore a year earlier.18
Revenue mix
- Share of revenue by specialty19
Item quarter to Jun 2026 Cardiac sciences 15% Orthopaedics 15% Neurosciences 11% Renal sciences 9% Gastric sciences 9% Mother and child 9% Oncology 7% Organ transplant 3% Others 22% - Share of revenue by who pays20
Item quarter to Jun 2026 Cash (patients paying themselves) 52% Insurance 32% Corporate (employers) 12% Aarogyasri (state government health scheme) 4%
Results by cluster
- In the year to Mar 2026, the Telangana cluster (Secunderabad, Kondapur, Begumpet, Gachibowli, Asian Transcare and MIPPL) had revenue of ₹22,420 million and EBITDA of ₹6,820 million, a 30.4% margin.21
- In the year to Mar 2026, the Andhra Pradesh cluster of 10 hospitals had revenue of ₹9,496 million and EBITDA of ₹2,337 million, a 24.6% margin.22
- The Maharashtra cluster (Nagpur, Nashik and Thane) had revenue of ₹4,654 million in the year to Mar 2026, when its occupancy (share of beds in use) rose to 52.1% from 33.0%, bringing it to EBITDA breakeven.23
- In Kerala, the Kannur and Kollam hospitals moved from an EBITDA loss of ₹97 million a year earlier to EBITDA of ₹78 million in the year to Mar 2026.24
Hospitals and beds
- At the end of Jun 2026, bed capacity was 7,459, of which 5,639 beds were operational, after 787 beds were added at Kondapur and 208 at Palakkad during the quarter.25
Expansion and capital spending
- In its presentation of 3 Aug 2026, the company said it plans to add 1,300+ beds through greenfield hospitals (built from scratch), acquisitions and O&M agreements (running hospitals that others own).26
- In its exchange filing of 21 Dec 2025, the company said it plans a hospital of about 300 beds in Chennai within 36 months, costing about ₹300 crore, on 1.168 acres of leased land, its first presence in Tamil Nadu.2728
- On its earnings call of 4 Aug 2026, the company said it expects about ₹100 to ₹125 crore of capital spending over the next 9 or so months on 3 projects, including a Rajahmundry hospital, and more overall once further projects are announced.29
What the company expects
- On its earnings call of 4 Aug 2026, the company said the enlarged Kondapur hospital could reach about ₹1,200 crore of annual revenue in 4 to 5 years, and that it models an EBITDA margin of about 30% at that level.3031
- On its earnings call of 4 Aug 2026, the company said occupancy in the Telangana cluster could reach 70% over 3 to 4 years, even with the new Kondapur and Secunderabad hospitals.32
- On its earnings call of 4 Aug 2026, the company said Kerala's EBITDA margin, in single digits now and through the current year, should reach the mid-teens in the next financial year and settle at about 20% to 22% over 2 to 3 years.33
- On its earnings call of 4 Aug 2026, the company said its Mahadevapura hospital had reached EBITDA breakeven and that it aims for the Bengaluru cluster to have zero EBITDA, with no losses, for the full year.34
Recent events
- On 6 Oct 2026, the board approved buying up to 51% of Sarvottam Health Care in Kakinada for up to ₹80.00 crore and up to 51% of Insignia Healthcare (KIMS-SIKHARA); KIMS already runs both for their owners under O&M agreements.3536
- On 20 Aug 2026, KIMS agreed to run Arete Hospitals in Gachibowli, Hyderabad, with 250 beds, for an initial 5 years for a fee of 9% of its net revenue, with an option to buy the business.373839
- On 7 Aug 2026, the stock exchanges approved in principle the issue of 77,02,182 warrants, each convertible into a share, to promoters Abhinay Bollineni and Adwik Bollineni and promoter-group entity Bharas Ventures LLP.40
- In Jun 2026, the company raised ₹1,500 crore through a qualified institutional placement (a share sale to large investors) and repaid loans; debt fell from ₹3,250 crore at the end of Mar 2026 to ₹2,570 crore at the end of Jun 2026.414243
Last updated
All 43 sources, each with its page
- 1. Annual report, 5 Aug 2026, page 29
- 2. Annual report, 5 Aug 2026, page 111
- 3. Annual report, 5 Aug 2026, page 6
- 4. Annual report, 5 Aug 2026, page 4
- 5. Annual report, 5 Aug 2026, page 14
- 6. Investor presentation, 3 Aug 2026, page 7
- 7. Annual report, 5 Aug 2026, page 20
- 8. Annual report, 5 Aug 2026, page 8
- 9. Annual report, 5 Aug 2026, page 5
- 10. Investor presentation, 3 Aug 2026, page 31
- 11. Investor presentation, 3 Aug 2026, page 15
- 12. Annual report, 5 Aug 2026, page 20
- 13. Annual report, 5 Aug 2026, page 96
- 14. Investor presentation, 3 Aug 2026, page 9
- 15. Annual report, 5 Aug 2026, page 17
- 16. Annual report, 5 Aug 2026, page 17
- 17. Earnings call, 4 Aug 2026, page 4
- 18. Earnings call, 4 Aug 2026, page 3
- 19. Investor presentation, 3 Aug 2026, page 28
- 20. Investor presentation, 3 Aug 2026, page 28
- 21. Annual report, 5 Aug 2026, page 19
- 22. Annual report, 5 Aug 2026, page 19
- 23. Annual report, 5 Aug 2026, page 19
- 24. Annual report, 5 Aug 2026, page 19
- 25. Investor presentation, 3 Aug 2026, page 20
- 26. Investor presentation, 3 Aug 2026, page 15
- 27. Exchange filing, 21 Dec 2025, page 1
- 28. Exchange filing, 21 Dec 2025, page 2
- 29. Earnings call, 4 Aug 2026, page 17
- 30. Earnings call, 4 Aug 2026, page 13
- 31. Earnings call, 4 Aug 2026, page 21
- 32. Earnings call, 4 Aug 2026, page 9
- 33. Earnings call, 4 Aug 2026, page 7
- 34. Earnings call, 4 Aug 2026, page 12
- 35. Exchange filing, 6 Oct 2026, page 1
- 36. Exchange filing, 6 Oct 2026, page 1
- 37. Exchange filing, 20 Aug 2026, page 1
- 38. Exchange filing, 20 Aug 2026, page 2
- 39. Exchange filing, 20 Aug 2026, page 3
- 40. Exchange filing, 7 Aug 2026, page 1
- 41. Earnings call, 4 Aug 2026, page 4
- 42. Earnings call, 4 Aug 2026, page 9
- 43. Earnings call, 4 Aug 2026, page 12
Results
Consolidated; ₹ crore.Krishna Institute of Medical Sciences quarterly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +30.9%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- −46.2%
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹1,180 Crup 9.76%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹37 Crup 12.99%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 3.2%
Revenue by quarter
Peak revenue ₹1,180 Cr, quarter to Jun 2026; lowest ₹772 Cr, quarter to Dec 2024
Net profit by quarter, a loss in red
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 777 | 772 | 797 | 872 | 961 | 998 | 1,075 | 1,180 |
| Net profit | 121 | 93 | 106 | 85 | 72 | 52 | 33 | 37 |
| Net margin | 15.5% | 12.0% | 13.3% | 9.8% | 7.5% | 5.2% | 3.1% | 3.2% |
Consolidated. The last eight quarters. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹3,905 Crup 28.65%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹242 Crdown 41.66%
- Net margin
- 6.2%
Revenue by year
Peak revenue ₹3,905 Cr, year to Mar 2026; lowest ₹1,330 Cr, year to Mar 2021
Net profit by year, a loss in red
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | 1,330 | 1,651 | 2,198 | 2,498 | 3,035 | 3,905 |
| Net profit | 205 | 344 | 366 | 336 | 415 | 242 |
| Net margin | 15.5% | 20.8% | 16.6% | 13.5% | 13.7% | 6.2% |
Consolidated. Years to March. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the year to Mar 2026 the company reports one business segment, Healthcare Activities, which carries all its revenue.
Valuation
Today, against the company's own history. Dividend yield is not shown: no dividend in the years on record.Krishna Institute of Medical Sciences PE ratio and valuation
Price to earnings
At or below today's level on 96% of 1,099 trading days since May 2022.
LowestHighest
Its median56.28Industry median42.64
Price to book
At or below today's level on 84% of 1,239 trading days over the last 5 years.
LowestHighest
Its median9.42Industry median4.47
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −2.8% | −37.3% | +54.9% | 0.0% |
| 3 years | +30.4% | −10.5% | +45.7% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add.
Mutual fund holdings
145 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 47 of the 72 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future. 1 more fund filed its first portfolio on record, holding it.All 145 funds holding Krishna Institute of Medical Sciences
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 5
- AddedAdded. Funds that held more shares than at the end of the month before.
- 42
- CutCut. Funds that held fewer shares than at the end of the month before.
- 30
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 67
- Sold outSold out. Funds that held it at the end of the month before and hold none at this month's end. Sold out in the glossary
- 8
| Fund | |||
|---|---|---|---|
 HDFC Small Cap FundHDFC Mutual Fund | 1,11,33,566 | 2.04% | ₹831.0 Cr |
 SBI Small Cap FundSBI Mutual Fund | 1,10,00,000 | 2.00% | ₹821.0 Cr |
 Axis Small Cap FundAxis Mutual Fund | 1,01,30,828 | 2.46% | ₹756.2 Cr |
 Kotak-Small Cap FundKotak Mahindra Mutual Fund | 84,54,118 | 3.30% | ₹631.0 Cr |
 Invesco India Small Cap FundInvesco Mutual Fund | 73,83,152 | 3.42% | ₹551.1 Cr |
| SBI Multicap FundSBI Mutual Fund | 65,00,000 | 2.07% | ₹485.2 Cr |
 Nippon India Small Cap FundNippon India Mutual Fund | 61,18,377 | 0.56% | ₹456.7 Cr |
| Axis Flexi Cap FundAxis Mutual Fund | 54,19,032 | 3.05% | ₹404.5 Cr |
| Kotak Flexi Cap FundKotak Mahindra Mutual Fund | 43,00,000 | 0.60% | ₹321.0 Cr |
| HDFC Aggressive Hybrid FundHDFC Mutual Fund | 42,00,000 | 1.48% | ₹313.5 Cr |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Promoter and insider buying and selling
Trades made since 28 Oct 2025.Krishna Institute of Medical Sciences insider trading
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade · 28 pledge filings of unclear kind
- Others: no market trade · 15 pledge filings of unclear kind
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Krishna Institute of Medical Sciences competitors and peers
Hospital, 39 listed companies, priced on 27 Oct 2026. The table lists the 8 companies closest to Krishna Institute of Medical Sciences in market cap.Healthcare companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Aster DM Quality CareASTERDM | 57,774 | 181.29 | – | +15.7% | +0.2% | 8.0% | 12.4% | 0.45% |
 Fortis HealthcareFORTIS | 55,603 | 53.06 | 5.62 | +17.5% | +20.7% | 11.1% | 12.7% | 0.14% |
 Narayana HrudayalayaNH | 35,011 | 42.90 | 7.72 | +57.8% | +3.9% | 20.0% | 13.1% | 0.26% |
 Global HealthMEDANTA | 33,894 | 60.94 | 8.56 | +21.3% | +4.1% | 15.1% | 14.2% | 0.04% |
 Dr. Agarwal's Health CareAGARWALEYE | 15,109 | 101.84 | 7.46 | – | – | 7.6% | 14.1% | 0.00% |
 Rainbow Childrens MedicareRAINBOW | 12,170 | 42.64 | 7.38 | +18.3% | +10.9% | 18.3% | 25.0% | 0.29% |
 Park Medi WorldPARKHOSPS | 9,921 | – | 4.91 | – | – | – | – | 0.00% |
 Yatharth Hospital & Trauma Care ServicesYATHARTH | 9,189 | 51.52 | 5.08 | +44.0% | – | 10.5% | 10.2% | 0.05% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Krishna Institute of Medical Sciences announcements
Oct 2026
26 Oct · Board meeting
19 Oct · Analysts
8 Oct · General Update On Query Received From BSE
7 Oct
6 Oct · Business
6 Oct · Business
Krishna Institute of Medical Sciences annual report, year to Mar 2026
Krishna Institute of Medical Sciences share price by year
Each calendar year to 2025.Krishna Institute of Medical Sciences share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 608.60 | +1.8% | 789.35 | 508.45 |
| 2024 | 598.00 | +51.1% | 622.85 | 364.08 |
| 2023 | 395.84 | +27.9% | 429.76 | 264.28 |
| 2022 | 309.46 | +8.5% | 322.06 | 224.52 |
| 2021 | 285.13 | – | 294.31 | 189.41 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2021 is from its first session, 28 Jun 2021.
Recent sessions
The 9 trading days to 26 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 26 Oct 2026 | 661.60 | 672.40 | 655.55 | 669.60 | 664.55 | 4,29,272 | 50.8% |
| 23 Oct 2026 | 665.00 | 672.55 | 657.00 | 665.15 | 663.74 | 2,42,425 | 46.4% |
| 22 Oct 2026 | 671.05 | 679.25 | 655.05 | 668.55 | 669.67 | 6,28,439 | 47.6% |
| 21 Oct 2026 | 680.95 | 683.00 | 661.30 | 674.10 | 671.43 | 3,77,457 | 58.9% |
| 19 Oct 2026 | 679.45 | 686.00 | 667.90 | 678.50 | 675.92 | 3,99,573 | 52.4% |
| 16 Oct 2026 | 688.80 | 690.90 | 675.00 | 685.60 | 680.38 | 1,47,530 | 46.9% |
| 15 Oct 2026 | 692.95 | 694.90 | 685.40 | 688.65 | 689.29 | 1,15,687 | 44.3% |
| 14 Oct 2026 | 708.00 | 708.00 | 689.30 | 692.95 | 696.07 | 2,17,795 | 40.9% |
| 13 Oct 2026 | 699.00 | 718.20 | 685.15 | 709.95 | 700.69 | 4,67,202 | 53.0% |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Stock split history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 13 Sep 2024 | Split | 0.2000 | Each share became 5. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.
Company details
- NSE symbol
- KIMS
- BSE code
- 543308
- ISIN
- INE967H01025
- Industry
- Healthcare Services
- Website
- www.kimshospitals.com
- CIN
- L55101TG1973PLC040558
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1973
- Registered office
- D. No. 1-8-31/1, Minister's Road, Secunderabad 500003, Telangana
- Share registrar
- MUFG Intime India Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments
In Nifty 500, BSE 500, Nifty Smallcap 250, BSE 250 SmallCap Index, BSE SmallCap, Nifty Total Market